Zinzino announced its preliminary financial results for the second quarter of 2026. Revenue in June for Zinzino’s sales markets reached $30 million, representing a 14% increase. Faun Pharma’s external sales increased as well, reaching $0.62 million. Overall group revenue in June increased by 15% year-over-year to $31.3 million.
In the second quarter, revenue in Zinzino sales markets grew 17% year-over-year to $94.7 million. Total revenues for the group also increased by 17% and totaled $96.3 million.
Accumulated revenue totals for the first six months of 2026 now total $191.8 million and represent a 22% increase from the first six months of 2025.
South America (Peru and Colombia) continues to show strong momentum, with 381% growth since its official launch earlier this year. North America (Canada, US, Mexico) was also a revenue driver, with a 62% growth rate.
